Wealthcare Advisory Partners’s Ocugen OCGN Stock Holding History

Wealthcare Advisory Partners’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-735	Closed	-$5K	–	1420
2021 Q1	$5K	Buy	+735	New	+$4.89K	﹤0.01%	1660

Other funds holding OCGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Wealthcare Advisory Partners's OCGN Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Ocugen (OCGN) in Q2 2021, closing a stake of 735 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in OCGN in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 129 funds tracked by Wall St. Rank hold OCGN as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Ocugen position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 735 Ocugen shares in Q2 2021, an estimated $5K.
Wealthcare Advisory Partners first reported a position in Ocugen in Q1 2021 and held it in 1 quarter.
Wealthcare Advisory Partners's Ocugen position peaked at $5K in Q1 2021.
129 funds tracked by Wall St. Rank held Ocugen as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.